171 results on '"Koch, Michael"'
Search Results
2. Alvimopan, a Peripherally Acting μ-Opioid Receptor Antagonist, is Associated with Reduced Costs after Radical Cystectomy: Economic Analysis of a Phase 4 Randomized, Controlled Trial
3. A Critical Assessment of Post-Prostatectomy Prostate Specific Antigen Doubling Time Acceleration—Is it Stable?
4. Tumor Focality Does Not Predict Biochemical Recurrence After Radical Prostatectomy in Men With Clinically Localized Prostate Cancer
5. A Parallel Randomized Clinical Trial Examining the Return of Urinary Continence after Robot-Assisted Radical Prostatectomy with or without a Small Intestinal Submucosa Bladder Neck Sling
6. Robotic versus Open Prostatectomy: End of the Controversy
7. EDITORIAL COMMENT
8. ADJUSTED CLINICAL OUTCOMES IN PATIENTS WITH SARCOMATOID VARIANT UROTHELIAL CARCINOMA UNDERGOING RADICAL CYSTECTOMY FOR MUSCLE INVASIVE DISEASE: PD33-03
9. EMPIRIC TREATMENT OF IDENTIFIED CLOSTRIDIUM DIFFICILE CARRIERS AT TIME OF CYSTECTOMY: PRELIMINARY OUTCOMES: MP56-02
10. A STUDY TO EVALUATE THE PROGNOSTIC AND PREDICTIVE UTILITY OF CCP AND HRD ASSAYS AND GENETIC SEQUENCING IN PATIENTS UNDERGOING NEOADJUVANT CHEMOTHERAPY IN BLADDER CANCER: MP49-02
11. LONG-TERM 10-YEAR HEALTH-RELATED QUALITY OF LIFE OUTCOMES FOLLOWING RADICAL CYSTECTOMY: MP38-13
12. IMPACT OF OBESITY ON WOUND COMPLICATIONS FOLLOWING RADICAL PROSTATECTOMY IS MITIGATED BY ROBOTIC TECHNIQUE: MP23-04
13. MP72-16 MANAGEMENT OF UNRESECTABLE BLADDER CANCER DIAGNOSED AT TIME OF PLANNED CYSTECTOMY
14. MP65-14 INCIDENCE AND RISK FOR CLOSTRIDIUM DIFFICILE INFECTIOUS COLITIS IN PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR BLADDER CANCER
15. MP64-17 LACK OF IMPROVEMENT IN RADICAL CYSTECTOMY OUTCOMES OVER 20 YEARS?
16. MP58-11 DOES SQUAMOUS DIFFERENTIATION PORTEND WORSE OUTCOMES IN UROTHELIAL BLADDER CANCER?
17. PD15-03 RANDOMIZED CLINICAL TRIAL EXAMINING THE RETURN OF URINARY CONTINENCE AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY WITH OR WITHOUT A BLADDER NECK SLING
18. Incidence and Risk Factors of Parastomal Hernia in Patients Undergoing Radical Cystectomy and Ileal Conduit Diversion
19. CAN LYMPHOVASCULAR INVASION BE USED AS A SURROGATE FOR LYMPH NODE INVOLVEMENT IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA?: MP77-18
20. PROPOSED NODAL STAGING CLASSIFICATION IN UROTHELIAL CARCINOMA OF THE BLADDER BASED ON BURDEN OF LYMPH LODE INVOLVEMENT: MP65-17
21. EFFICACY OF NEOADJUVANT CHEMOTHERAPY IN BLADDER CANCER: MP55-19
22. SIGNIFICANCE OF LYMPH NODE INVOLVEMENT IN VARIANT HISTOLOGY UROTHELIAL BLADDER CANCER: MP55-07
23. RANDOMIZED CLINICAL TRIAL EXAMINING THE RETURN OF EARLY URINARY CONTINENCE AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY WITH OR WITHOUT A BLADDER NECK SLING: MP37-11
24. Randomized, Controlled Trial of Spaced Education to Urology Residents in the United States and Canada
25. Phase I/II Trial of High Intensity Focused Ultrasound for the Treatment of Previously Untreated Localized Prostate Cancer
26. Should the Patient With Positive Margins After Radical Prostatectomy Receive Adjuvant Radiation?
27. Use of Ileum as Ureteral Replacement in Urological Reconstruction
28. LYMPHOVASCULAR INVASION IS AN INDEPENDENT PROGNOSTIC FACTOR IN PROSTATIC ADENOCARCINOMA
29. PREOPERATIVE PREDICTION OF SMALL VOLUME CANCER (LESS THAN 0.5 ML) IN RADICAL PROSTATECTOMY SPECIMENS
30. Focal Prostate Therapy
31. FACE AND CONSTRUCT VALIDATION OF A NOVEL VIRTUAL REALITY ROBOTIC SIMULATOR: 1920
32. ROBOTIC VS. OPEN RADICAL PROSTATECTOMY: A SINGLE INSTITUTION, SINGLE SURGEON COMPARISON OF OUTCOME: 1778
33. Re: Editorial Comments
34. Positive Margins in Urological Oncology
35. Tertiary Gleason Pattern 5 is a Powerful Predictor of Biochemical Relapse in Patients With Gleason Score 7 Prostatic Adenocarcinoma
36. Complications of Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Testis Cancer
37. PERINEURAL INVASION IN RADICAL PROSTATECTOMY SPECIMENS: LACK OF PROGNOSTIC SIGNIFICANCE
38. TRANSITIONAL CELL CARCINOMA OF THE BLADDER FOLLOWING AUGMENTATION CYSTOPLASTY FOR THE NEUROPATHIC BLADDER
39. Early Catheter Removal After Radical Retropubic Prostatectomy: Long-term Followup
40. Teratoma in the Orchiectomy Specimen and Volume of Metastasis are Predictors of Retroperitoneal Teratoma in Post-Chemotherapy Nonseminomatous Testis Cancer
41. Major Complications in 213 Laparoscopic Nephrectomy Cases: The Indianapolis Experience
42. AORTIC REPLACEMENT DURING POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION
43. ACCURACY OF PREDICTING LONG-TERM PROSTATE SPECIFIC ANTIGEN OUTCOME BASED ON EARLY PROSTATE SPECIFIC ANTIGEN RECURRENCE RESULTS AFTER RADICAL PROSTATECTOMY
44. EARLY POST-PROSTATECTOMY PELVIC FLOOR BIOFEEDBACK
45. CHARACTERIZATION AND PREDICTORS OF PROSTATE SPECIFIC ANTIGEN PROGRESSION RATES AFTER RADICAL RETROPUBIC PROSTATECTOMY
46. Editorial Comment
47. PD15-08 DOES CARCINOMA IN-SITU RESPOND TO CISPLATINUM-BASED NEOADJUVANT CHEMOTHERAPY?: IMPACT ON PATIENT SELECTION FOR ORGAN PRESERVATION
48. MP11-19 TARGETED LYMPH NODE DISSECTION AT RADIOTRACER-AVID SITES IN RECURRENT PROSTATE CANCER: AN EARLY ASSESSMENT OF EFFICACY
49. EDITORIAL: PREDICTING OUTCOMES AFTER RADICAL PROSTATECTOMY
50. Prostate Cancer: Biology, Diagnosis and Management
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.